Robinson Value Management’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-13,452
| Closed | -$1.33M | – | 80 |
|
|
2024
Q3 | $1.33M | Buy |
13,452
+155
| +1% | +$15.3K | 0.86% | 44 |
|
|
2024
Q2 | $1.23M | Sell |
13,297
-373
| -3% | -$34.6K | 0.86% | 41 |
|
|
2024
Q1 | $1.3M | Buy |
+13,670
| New | +$1.3M | 0.87% | 40 |
|
|
2023
Q1 | – | Sell |
-7,963
| Closed | -$661K | – | 75 |
|
|
2022
Q4 | $661K | Buy |
+7,963
| New | +$661K | 0.57% | 43 |
|
|
2021
Q1 | – | Sell |
-2,401
| Closed | -$338K | – | 68 |
|
|
2020
Q4 | $338K | Buy |
+2,401
| New | +$338K | 0.32% | 52 |
|
|
2018
Q3 | $366K | Sell |
3,819
-1,045
| -21% | -$100K | 0.34% | 53 |
|
|
2018
Q2 | $463K | Buy |
+4,864
| New | +$463K | 0.42% | 46 |
|